Description
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
| Purity | ≥98% |
|---|---|
| Formula | C25H39H7O8 |
| Formula Wt. | 565.63 |
| Synonym | EHIPA. |
| Solubility | Soluble in water (2 mg/mL). |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Gartner TK, Loudon R, Taylor DB. The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of a fibrinogen binding domain of glycoprotein IIb/IIIa. Biochem Biophys Res Commun. 1991 Nov 14;180(3):1446-52. PMID: 1953789.
Aromatase inhibitor.
MEK inhibitor.
Nucleotide (guanine) analog, prevents guanine s...
Pim-1 inhibitor.
PARP inhibitor.
FGFR inhibitor.
Quinoid diterpene found in species of Salvia; S...
Triterpenoid
Bufanolide steroid found in Bufo arenarum;VEGFR...
Anti-metastatic
Mesalazine derivative, sulfa drug; sepiapterin ...
Mixture of Ginkgolides A, B and C, found in Gin...
Protein translation inhibitor.
NSAID; COX-2 inhibitor.
S-enantiomer of citalopram; SERT inhibitor.
Lincosamide; ribosomal translocation and protei...
Triterpene saponin found in species of Panax; A...
Endogenous NMDA receptor antagonist.
Non-selective CB receptor agonist.
TrkB agonist.